Cargando…
Preliminary results of clinical use of colchicine in COVID-19 treatment
We report a case of the use of colchicine in a patient infected with SARS-CoV-2 virus. A 37-year-old man with COVID-19 presented with moderate symptoms, mild pulmonary impairment and elevated inflammatory markers, suggesting an increased risk of cytokine storm and possible worsening of clinical cond...
Autores principales: | Knack, Rafael Silvestre, Losso, Luis Carlos, Knack, Renata Silvestre, Hanada, Talie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323388/ https://www.ncbi.nlm.nih.gov/pubmed/34326122 http://dx.doi.org/10.1136/bcr-2021-244482 |
Ejemplares similares
-
Hashimoto’s thyroiditis following SARS-CoV-2 infection
por: Knack, Rafael Silvestre, et al.
Publicado: (2021) -
The Use of Liraglutide in Obese Patients With COVID-19: A Case Report
por: Hanada, Taliê Zanchetta Buani, et al.
Publicado: (2021) -
Iridium-related deep levels in n-type silicon
por: Bollmann, J, et al.
Publicado: (2000) -
COVID-19 cardiac injury and the use of colchicine
por: Anton-Vazquez, Vanesa, et al.
Publicado: (2021) -
Colchicine plus Dapsone in Colchicine‐Resistant FMF Patients
por: Salehzadeh, Farhad, et al.
Publicado: (2019)